Comments

Legend Biotech Stock Price, Quotes and Forecasts

Q: What sector and industry does Legend Biotech (LEGN) operate in?

Legend Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

LEGNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$28.91

-0.14-0.48%

At close: -

$29.13

0.220.76%

After Hours: 7:51 PM EDT

Legend Biotech (LEGN) Forecast

News Earnings Legend Biotech (LEGN) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Legend Biotech Stock Price, Quotes and Forecasts | NASDAQ:LEGN | Benzinga

Explore Legend Biotech stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LEGN.

Open	$28.88
Close	$28.91
Volume / Avg.	1.51M / 1.49M
Day Range	$28.47 - $29.40
52 Wk Range	27.34 - 60.87
Market Cap	$5.34B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	7.01%
Days to Cover	5.44

Recent News

Netflix, Ericsson, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday (CORRECTED)

Avi Kapoor

Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst

Legend Biotech's Carvykti shows strong efficacy in multiple myeloma as U.S.-based manufacturing shields it from tariffs and global regulatory risks.

Vandana Singh

Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients

Johnson & Johnson and Legend Biotech presented new data from the Phase 3 CARTITUDE-4 study, showing Carvykti significantly extends survival in multiple myeloma patients, reducing the risk of death by 45% compared to standard therapies.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$28.88
Close	$28.91
Volume / Avg.	1.51M / 1.49M
Day Range	$28.47 - $29.40
52 Wk Range	27.34 - 60.87
Market Cap	$5.34B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	7.01%
Days to Cover	5.44

About Legend Biotech Corp

Sector

Health Care

Industry

Biotechnology

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery an...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Legend Biotech (LEGN) stock?

You can purchase shares of Legend Biotech (NASDAQ:LEGN) through any online brokerage.

View our list of the best stock brokerages

Who are Legend Biotech (LEGN) competitors?

Other companies in Legend Biotech’s space includes: Avidity Biosciences (NASDAQ:RNA), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Ionis Pharmaceuticals (NASDAQ:IONS) and Roivant Sciences (NASDAQ:ROIV).

What is the forecast, or price target, for Legend Biotech (LEGN) stock?

Legend Biotech has a consensus price target of $78.53.

What is the current price for Legend Biotech (LEGN)?

The stock price for Legend Biotech (NASDAQ: LEGN) is $29.13 last updated May 23, 2025 at 7:51 PM EDT.

Does Legend Biotech (LEGN) pay a dividend?

There are no upcoming dividends for Legend Biotech.

When is Legend Biotech (NASDAQ:LEGN) reporting earnings?

Legend Biotech’s Q2 earnings are confirmed for Friday, August 8, 2025.

Is Legend Biotech (LEGN) going to split?

There is no upcoming split for Legend Biotech.

What sector and industry does Legend Biotech (LEGN) operate in?

Legend Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.